Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Adv Drug Deliv Rev. 2016 Aug 9;113:157–176. doi: 10.1016/j.addr.2016.08.001

Table 2.

Selected Multi-component Radiolabeled Nanoparticle Systems

Component 1 Component 2 Imaging Modality Therapeutic
Modality
References
Silica Gold Nanoshell PET −/− [192, 193]
PET PTT [194]
Gold Nanosphere PET Chemotherapy, PTT [316]

SPION Silica PET/MR −/− [34, 35]
SPECT/MR −/− [238]
SPECT/MR/FL Stem Cell Therapy [236]
Gold PET/MR/FL −/− [204]
Al(OH)3 PET/MR −/− [248]
Crosslinked Dextran PET/CT −/− [250]
Melanin PET/MR/PAT/PTI PTT [304]

QDs Phospholipid Micelles PET/FL −/− [112]

UCNP Porphyrin
phospholipid
PET/PA/FL/UCL/CT/
Cerenkov
−/− [140]
Micelle PET/UCL −/− [139]

Graphene Gold Nanorod Vesicle PET/PAT PT, Drug Delivery [96]
SPION PET/MR/PAT −/− [89]

CuS Silica PET PTT [33]
Ferritin PET/PAT PTT [309]

MoS2 SPION PET/PAT/MR PTT [286]

Bi2Se3 FeSe2 PET/CT/MR/PAT PTT, RT [287]

PTI = Photothermal Imaging, PAT = Photoacoustic Tomography